title: Bioresorbable vascular scaffold for coronary in-stent restenosis: a novel concept.
abstract: The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is still not well defined. Various treatment modalities include plain old balloon angioplasty (POBA), metallic stent, cutting or scoring balloon and drug-eluting balloon (DEB). Bioresorbable vascular scaffold (BVS) is the latest technology for the treatment of de novo coronary artery lesions. The use of BVS in ISR is based on the rationale of local drug delivery as achieved by DEB without the permanent bi-layer of metal and also stabilizes dissection flaps and prevents acute recoil as provided by metallic stent. To the best of our knowledge this is the first case report of the use of BVS in patient with ISR.
authors.affiliation: Department of Cardiology, Apex Heart Institute, Mondeal Business Park, SG Highway, Ahmedabad, Gujarat 380006, India. Electronic address: drsdeora@gmail.com.
authors.forename: Surender
authors.initials: S
authors.lastname: Deora
authors.affiliation: Department of Cardiology, Apex Heart Institute, Mondeal Business Park, SG Highway, Ahmedabad, Gujarat 380006, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Shah
authors.affiliation: The Commonwealth Medical College, Scranton, PA, USA.
authors.forename: Samir
authors.initials: S
authors.lastname: Pancholy
authors.affiliation: Department of Cardiology, Apex Heart Institute, Mondeal Business Park, SG Highway, Ahmedabad, Gujarat 380006, India.
authors.forename: Tejas
authors.initials: T
authors.lastname: Patel
mesh_terms: D020341:Absorbable Implants; D000328:Adult; D001672:Biocompatible Materials; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000628:therapy*; D054855:Drug-Eluting Stents; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D020123:Sirolimus / Q000008:administration & dosage; D054457:Tissue Scaffolds
chemical_list: D001672:Biocompatible Materials; D007166:Immunosuppressive Agents; D020123:Sirolimus
keywords: Bioresorbable vascular scaffold; Drug-eluting balloon; Drug-eluting stent; In-stent restenosis